Interstitial Lung Disease with Progressive Fibrotic Phenotype in Diseases Classified Elsewhere

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Interstitial Lung Disease with Progressive Fibrotic Phenotype in Diseases Classified Elsewhere trials may be worth asking about

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT06732674

Home Based Clinical Management of Interstitial Lung Disease in Systemic Rheumatic Diseases

The RMD-mILDer trial is a home monitoring strategy trial aiming to improve management of interstitial lung disease related to rheumatic diseases applying eHealt…

Norway218 participantsStarted 2024-12-16Updated 2024-12-19

Treatment: A home monitoring strategy with event driven management

All recent trials (2 shown)

Active — Not RecruitingPhase 2

NCT06329401

A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis

A randomized, double-blind, placebo-controlled clinical study to evaluate the safety and efficacy of 2 doses of inhaled pirfenidone (AP01) versus placebo on top…

United States, Argentina +12 more375 participantsStarted 2024-04-03Updated 2026-06-18

Treatment: AP01, Placebo